We are live on ! Find out more
USNA icon

Usana Health Sciences

149 hedge funds and large institutions have $609M invested in Usana Health Sciences in 2016 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 14

6% more funds holding

Funds holding: 140149 (+9)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

12% less capital invested

Capital invested by funds: $693M → $609M (-$84.2M)

43.32% less ownership

Funds ownership: 84.1%40.78% (-43%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
149
Holders Change
+9
Holders Change %
+6.43%
% of All Funds
3.73%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
24
Increased
50
Reduced
50
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$3.64M -$585K -8,977 -13%
Prudential Financial
27
Prudential Financial
New Jersey
$3.49M -$1.56M -23,920 -30%
Invesco
28
Invesco
Georgia
$3.48M +$3.13M +48,062 +548%
AQR Capital Management
29
AQR Capital Management
Connecticut
$3.18M -$938K -14,396 -22%
Marshall Wace
30
Marshall Wace
United Kingdom
$3.12M -$460K -7,061 -12%
SIM
31
Spark Investment Management
New York
$2.63M +$785K +12,050 +39%
CEI
32
Clark Estates Inc
New York
$2.45M
BIM
33
BlackRock Investment Management
Delaware
$2.4M -$18.9K -290 -0.7%
GCP
34
GSA Capital Partners
United Kingdom
$2.29M -$920K -14,128 -27%
Ameriprise
35
Ameriprise
Minnesota
$2.28M -$92.4K -1,418 -4%
MAM
36
Martingale Asset Management
Massachusetts
$2.25M +$121K +1,859 +5%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$2.09M -$713K -10,946 -24%
Barclays
38
Barclays
United Kingdom
$1.95M +$866K +13,285 +72%
MC
39
Menta Capital
California
$1.89M -$61.5K -944 -3%
PP
40
PDT Partners
New York
$1.88M +$26.6K +408 +1%
RCAMU
41
Rothschild & Co Asset Management US
Connecticut
$1.77M +$1.63M +25,090 +653%
Goldman Sachs
42
Goldman Sachs
New York
$1.67M -$3.82M -58,693 -68%
HI
43
HBK Investments
Texas
$1.62M -$440K -6,760 -20%
UBS Group
44
UBS Group
Switzerland
$1.57M -$444K -6,820 -21%
Russell Investments Group
45
Russell Investments Group
United Kingdom
$1.53M +$1.61M +24,693 New
PPA
46
Parametric Portfolio Associates
Washington
$1.48M -$299K -4,582 -16%
CIA
47
Capital Impact Advisors
Massachusetts
$1.4M
CS
48
Credit Suisse
Switzerland
$1.32M +$429K +6,583 +44%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.31M -$39.1K -600 -3%
LSV Asset Management
50
LSV Asset Management
Illinois
$1.3M -$105K -1,611 -7%

USNA Hedge Fund Activity: Q4 2016 in Review

149 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2016, worth a combined $609M — down 12% from $693M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 14 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $3.74M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $7.87M sold.

  • 149 institutional investors held Usana Health Sciences (USNA) as of Q4 2016, up from 140 in Q3 2016.
  • Funds reported $609M of Usana Health Sciences stock for Q4 2016, down 12% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q4 2016 and 14 closed out, a net change of +10 holders.
  • The largest Usana Health Sciences buyer in Q4 2016 was Phocas Financial Corp, an estimated $3.74M added.
  • The largest Usana Health Sciences seller in Q4 2016 was Two Sigma Investments, an estimated $7.87M sold.

Based on aggregated 13F filings for Q4 2016.